These results suggest that decreased proliferation of activated HSCs, which has been shown to contribute to reduced cirrhosis (47), could partly explain the association of IFNL4 genotype with reduced cirrhosis in patients with HCV. Here, IFNL4 is linked to Cirrhosis.